Mrutyunjaya Panda

Mr. Mrutyunjaya Panda

Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, Heraklion, Greece
orcid
Marie Curie Doctoral Research Fellow

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Dharmendra KashyapDharmendra Kashyap
Dharmendra Kashyap
Mrutyunjaya PandaMrutyunjaya Panda
Mrutyunjaya Panda
BBBudhadev Baral
Budhadev Baral
NVNidhi Varshney
Nidhi Varshney
SRSajitha R
Sajitha R
HJHem Chandra Jha
Hem Chandra Jha
Vaccine adjuvants are substances that improve the immune capacity of a recombinant vaccine to a great extent and have been in use since the early 1900s; they are primarily short-lived and initiate antigen activity, mainly an inflammatory response. With the developing technologies and innovation, early options such as alum were modified, yet the inorganic nature of major vaccine adjuvants caused several side effects. Outer membrane vesicles, which respond to the stressed environment, are small nano-sized particles secreted by gram-negative bacteria. The secretory nature of OMV gives us many benefits in terms of infection bioengineering. This article aims to provide a detailed overview of bacteria’s outer membrane vesicles (OMV) and their potential usage as adjuvants in making OMV-based vaccines. The OMV adjuvant-based vaccines can be a great benefactor, and there are ongoing trials for formulating OMV adjuvant-based vaccines for SARS-CoV-2. This study emphasizes engineering the OMVs to develop better versions for safety purposes. This article will also provide a gist about the advantages and disadvantages of such vaccines, along with other aspects.

20 April 2021 in Free Radical Research
Verified
Journal Article
Closed access
MMMonalisa Mishra
Monalisa Mishra
Mrutyunjaya PandaMrutyunjaya Panda
Mrutyunjaya Panda
Nanotechnology is a rapidly developing technology in the twenty-first century. Nanomaterials are extensively used in numerous industries including cosmetics, food, medicines, industries, agriculture, etc. Along with its wide application toxicity is also reported from studies of various model organisms including Drosophila. The toxicity reflects cytotoxicity, genotoxicity, and teratogenicity. The current study correlates the toxicity as a consequence of reactive oxygen species (ROS) generated owing to the presence of nanoparticles with the living cell. ROS mainly includes hydroxyl ions, peroxide ions, superoxide anions, singlet oxygen, and hypochlorous acids. An elevated level of ROS can damage the cells by various means. To protect the body from excess ROS, living cells possess a set of antioxidant enzymes which includes peroxidase, glutathione peroxidase, and catalase. If the antioxidant enzymes cannot nullify the elevated ROS level than DNA damage, cell damage, cytotoxicity, apoptosis, and uncontrolled cell regulations occur resulting in abnormal physiological and genotoxic conditions. Herewith, we are reporting various morphological and physiological defects caused after nanoparticle treatment as a function of redox imbalance.

20 October 2024 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
Mrutyunjaya PandaMrutyunjaya Panda
Mrutyunjaya Panda
MMMaria Markaki
Maria Markaki
Nektarios TavernarakisNektarios Tavernarakis
Nektarios Tavernarakis

17 July 2025 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
Mrutyunjaya PandaMrutyunjaya Panda
Mrutyunjaya Panda
MFMaria Fakitsa
Maria Fakitsa
MMMaria Markaki
Maria Markaki
Nektarios TavernarakisNektarios Tavernarakis
Nektarios Tavernarakis